Eight new hydroquinone derivatives, gliomastins A-D (1-4), 9-O-methylgliomastin C (5), acremonin A 1-Ob-D-glucopyranoside (6), gliomastin E 1-O-b-D-glucopyranoside (7), and 6
Introduction
Marine-derived microorganisms are attracting considerable attention owing to their high potential for producing new bioactive secondary metabolites.
1,2 Unique and stressful marine habitats, such as those characterized by extreme pressure, changing levels of salinity or temperature, may have a great impact on fungal biological activity. 3 One of the ecologically most diverse marine ecosystems are coral reefs. 4, 5 In recent years, numerous bioactive secondary metabolites derived from coral-associated fungi have been reported. 3 Examples include the prenylated polyketides territrems A-C, which were isolated from the fungus Aspergillus terreus obtained from the gorgonian Echinogorgia aurantiaca, which exhibit pronounced acetylcholinesterase inhibitory activity. 6 Hydroanthraquinones and anthraquinone dimers, which were isolated from the so coral-derived fungus Alternaria sp., showed cytotoxicity against PC-3 and HCT-116 tumor cell lines. 7 In addition, the structurally unique 14-membered resorcylic acid lactones cochliomycins A-C, which exhibit antifouling activity, were isolated from the gorgonian-derived fungus Cochliobolus lunatus. 8 As a part of our ongoing exploration of bioactive metabolites from fungi, [9] [10] [11] [12] examination of the Red Sea derived hard coral Stylophora sp. collected in Egypt, afforded different fungal strains from the coral tissues, 9 one of which was identied as Gliomastix sp. So far only few secondary metabolites have been reported from the genus Gliomastix, including the macrolides gliomasolide A-E, 13 the dihydroxanthenones muroxanthenone A-E, 14, 15 as well as quinone/hydroquinone meroterpenoids.
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The crude extract of the solid rice culture of Gliomastix sp. in this study showed cytotoxic activity against the L5178Y mouse lymphoma cell line with inhibition rate of 69.1% at a dose of 10 mg mL À1 . Chromatographic workup of the fungal extract afforded een hydroquinone derivatives including eight new natural products (1) (2) (3) (4) (5) (6) (7) (8) . Herein, we report the isolation, structure elucidation as well as cytotoxic and antimicrobial activity of the isolated compounds.
Results and discussion
Compound 1 was isolated as a yellow amorphous powder. Its molecular formula was determined to be C 22 shown, for which the trivial name gliomastin A is proposed. The relative conguration of 1 was determined by ROESY data (Fig. 1) To determine the absolute conguration of 1, the solution TDDFT-ECD method was applied on the arbitrarily chosen (5S,6R,8S,7 0 R)-1 enantiomer. 18, 19 The 14 MMFF conformers obtained in the conformational search of the NMR calculations were reoptimized at the B3LYP/6-31G(d), B97D/TZVP 20,21 PCM/ MeCN and CAM-B3LYP/TZVP 22,23 PCM/MeCN levels and ECD computations were performed for the low-energy conformers with various functionals (B3LYP, BH&HLYP, CAM-B3LYP, PBE0) combined with the TZVP basis set. Computed ECD spectra obtained at all of the applied combination of levels gave moderate to good mirror-image agreement with the experimental spectrum, allowing determination of the absolute conguration of 1 as (5R,6S,8R,7 0 S) (Fig. 2 ).
Gliomastin A (1) features a new carbon skeleton, which could be derived from two co-isolated known hydroquinone derivatives acremonin A (11) 24 and F-11334A 1 (13) . 25, 26 A biosynthetic pathway from the latter two compounds to 1 via Diels-Alder reaction is proposed (Fig. 3) .
The molecular formula of compound 2 was established as C 13 and C-1 0 (d C 167.6), combined with its molecular formula, indicated that the isolated methylene CH 2 -2 0 was linked to the benzene ring via an amide bond and a sulfur atom at the C-1 and C-2 positions to form an additional ring. Thus, the structure of 2 was determined, representing a rare sulfur-containing alkaloid, of which the co-isolated known hydroquinone derivative F-11334A 1 (13) could be the precursor. Gliomastin C (3) was recovered as a white amorphous powder, possessing the molecular formula C 11 H 12 O 3 as determined by HRESIMS. Its 1 H NMR data (Table 2) A hydroxy group at C-4 and an oxygen bridge between C-1 and C-8 were assigned in consideration of the molecular formula and the chemical shis of the corresponding carbons. Thus, the structure of gliomastin C (3) was elucidated as shown. Gliomastin D (4) shared the same molecular formula as gliomastin C (3). The UV spectra and NMR data ( Table 2 ) of 4 were also comparable to those of 3. Three aromatic protons belonging to an ABX coupling system at d H 7.29 (d, H-2), 6.98 (d, H-5) and 6.80 (dd, H-3) were found in addition to a singlet olenic methine at d H 6.63 (H-7) and two singlet methyls at d H 1.55 (Me-10 and 11). Analysis of the 1D and 2D NMR spectra of 4 revealed that the two compounds were structurally similar except for the position of the hydroxy group and the oxygen bridge. The upeld shied C-8 (À4.4 ppm) and downeld shied C-9 (+4.7 ppm) in 4 compared to those of 3 suggested the presence of a pyran ring and a hydroxy group at C-8 in 4 instead of a furan ring. Compound 5 was isolated as a white amorphous powder with the molecular formula C 12 H 14 O 3 as established by HRE-SIMS, containing an additional CH 2 unit compared to gliomastin C (3). The UV absorption spectrum and NMR data ( Table  2) of 5 resembled those of 3 except for the appearance of an additional methoxy group at d C 51.3 and d H 3.10, which was further conrmed to be located at C-9 by the HMBC correlation from the protons of the methoxy group to C-8 (d C 74.9). Thus, compound 5 was elucidated as 9-O-methylgliomastin C.
The HRESIMS of compound 6 displayed a pseudomolecular ion peak at m/z 361. 1255 24 Acid hydrolysis of 6 yielded two products, one of which was conrmed to be the co-isolated hydroquinone acremonin A (11) by comparison of their NMR data and optical rotation values. 24 The other product was determined as b-Dglucopyranose by TLC analysis and optical rotation measurement compared to a known standard as well as by the J value (7.7 Hz) of the anomeric proton (H-1 0 ) in 6. Along with the 1D and 2D NMR spectra, compound 6 was unambiguously determined to contain an acremonin A moiety and a glucopyranose residue (Fig. 5) . However, the HMBC correlations from H- Since the absolute conguration of acremonin A (11) is unknown in literature, ECD calculations were carried out for the arbitrarily chosen (S) enantiomer of the aglycone 11. DFT reoptimization of the initial 15 MMFF conformers yielded 8 lowenergy conformers at both the B3LYP/6-31G(d) in vacuo and the B97D/TZVP PCM/MeCN levels of theory. ECD spectra computed at various levels for these conformers gave nice mirror-image agreement with the experimental spectrum (Fig. 6 ). In some of the higher-energy conformers (e.g. conformers C and D, Fig. 7 ), the isopropenyl adopted a different orientation from that of the lowest-energy conformer, which is reected in a near mirror image ECD of the conformers. Considering the relatively small computed energy differences of the conformers, this might be a possible source of error (energy difference between conformers A and C is less than 1 kJ mol À1 ). 18,21 Therefore OR calculations were also performed on the low-energy gas-phase conformers and on those reoptimized at the B97D/TZVP PCM/ MeOH level (8 conformers over 2% also at this level).
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The OR calculations performed at various levels for both sets of conformers were in line with the ECD results conrming the previous assignment. However, the sign of the OR values of the individual conformers were inuenced by the orientation of isopropenyl group such as in the case of ECD. The (R) absolute conguration of the calculations was also conrmed by the biosynthetic relationship of 1 and 11.
Compound 7 was obtained as a white solid. It possesses the molecular formula C 17 H 24 O 8 as established by analysis of the HRESIMS data. Similar to 6, the NMR data (Table 3) (Fig. 5) . Analysis of the hydrolysis products of 7 conrmed the presence of a glucopyranose residue, which was determined to be attached to C-1 by the HMBC correlation from H-1 0 to C-1. However, compared to 6, the signals of the isopropenyl group were replaced by two singlet methyl groups at d H 1.35 (s, Me-10) and 1.20 (s, Me-11) as well as by an oxygenated methine at d C 82.2 and d H 3.99 (CH-8).
The COSY correlations between H-7a/H-8 and H-7b/H-8 together with the HMBC correlations from Me-10 and Me-11 to C-5, C-8 and C-9 (d C 48.4), and from H-7a and H-7b to C-1, C-5 and C-6 indicated the presence of a further cyclopentene ring with two methyls at C-9 and a hydroxy group at C-8, which was fused to the benzene ring. Thus, the structure of 7 was elucidated as shown. Its aglycone was obtained following hydrolysis of 7, representing a new hydroquinone derivative, for which the name gliomastin E is proposed. For the congurational assignment of the aglycone gliomastin E, the solution TDDFT-ECD calculation protocol was carried out on the arbitrarily chosen (S) enantiomer. Reoptimization of the initial 23 MMFF conformers resulted in 13 and 15 low-energy ($2%) conformers at the B3LYP/6-31G(d) in vacuo and the B97D/TZVP PCM/MeCN levels. ECD spectra computed at various levels for both sets of conformers resembled the 247 and the 198 nm transitions of gliomastin E suggesting (S) absolute conguration (Fig. 8) . Since the 273 nm positive Cotton effect (CE) could not be reproduced by any of the applied combination, OR calculations performed in vacuo and in MeOH (similarly to 11) were applied to prove the (S) absolute cong-uration. 28 OR values computed at all of the applied combinations of levels resulted in small positive overall optical rotations in the range from +10.2 to +18.4, while the experimental value was +15.2, which veried the ECD results. The molecular formula C 15 H 20 O 8 was deduced for compound 8 from the HRESIMS data. The UV spectrum and NMR data ( the carbonyl carbon of the acetoxy group. The remaining structure of 8 was conrmed to be the same as 9 by detailed analysis of the 2D NMR spectra of 8 (Fig. 5) . The hexose residue was determined to be b-D-glucopyranose by the coupling constant (7.6 Hz) of the anomeric proton (H-1 0 ) and analysis of the acid hydrolysis products of 8 in comparison with a known standard. Owing to the data mentioned above, compound 8 was elucidated as 6 0 -O-acetyl-isohomoarbutin.
By comparison with the literature data, the remaining known compounds were identied as isohomoarbutin (9) (14), 34 and 2,2-dimethylchroman-3,6-diol (15).
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All isolated compounds (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) were evaluated for their cytotoxicity against the L5178Y murine lymphoma cell line (Table 4) . Compounds 1, 10, 12 and 13 showed signicant cytotoxic activity with IC 50 values of 1.8, 1.0, 1.1 and 3.0 mM, respectively, which are below that of the positive control kahalalide F. Compared to the two precursors 11 and 13, compound 1 demonstrated stronger cytotoxicity while the sulfurcontaining alkaloid 2 was inactive compared to its precursor 13. Compounds 10 and 11 showed strong cytotoxicity while their glycosides 8, 9 and 6 were inactive. The ether bridge in 14 and 15 led to total loss of cytotoxicity compared to 13.
In addition, all compounds were tested for their antitubercular activity against Mycobacterium tuberculosis and for their antibacterial activities against different strains of pathogenic bacteria (Table 4 ). Only compounds 10 and 12 exhibited antibacterial activity but they were also cytotoxic. Compound 3, which lacked cytotoxicity, showed antitubercular activity with a MIC value of 12.5 mM. Comparison of the antitubercular activity of 3 with those of 4, 5, 14 and 15 indicated the importance of the furan ring and of the free hydroxy group at C-9.
In conclusion, our investigation of secondary metabolites from the marine-derived fungus Gliomastix sp. led to the isolation of een hydroquinone derivatives including eight new natural products (1) (2) (3) (4) (5) (6) (7) (8) . Among the latter, the dimer 1 possesses a novel carbon skeleton, which could be derived from derivatives of 11 and 13 through a Diels-Alder reaction. Compound 1 also exhibited signicant cytotoxicity against the L5178Y mouse lymphoma cell line with an IC 50 value of 1.8 mM.
Compound 2 is a rare sulfur-containing alkaloid. TDDFT-ECD and OR calculations were performed to determine the absolute congurations of 1 and the aglycones of 6 and 7. All isolated compounds were tested for their cytotoxic and antimicrobial activity and the structure-activity relationships were discussed.
Experimental section

General procedures
Optical rotations were recorded on a PerkinElmer-241 MC polarimeter.
1 H, 13 C and 2D NMR spectra were measured on a Bruker Avance DMX 600 NMR spectrometer. A Finnigan LCQ Fig. 8 Experimental ECD spectrum of gliomastin E in MeCN (black line) compared with the B3LYP/TZVP ECD spectra computed for the B3LYP/6-31G(d) in vacuo optimized low-energy conformers of (S)-gliomastin E (average of 13 conformers, red line) and (R)-gliomastin E (average of 13 conformers, blue line). Bars represent computed rotational strength values of the lowest-energy conformer of (S)-gliomastin E. E. faecium ATCC 700221 Deca XP Thermoquest spectrometer was used to record mass spectra while a FTHRMS-Orbitrap (Thermo Finnigan) mass spectrometer was utilized to obtain HRESIMS data. The Dionex P580 HPLC system was coupled to a photodiode array detector (UVD340S) and the analytical column (125 Â 4 mm, L x i.d.) was prelled with Eurospher-10 C 18 (Knauer, Germany). Semipreparative HPLC separation was performed on a LachromMerck Hitachi HPLC system (Pump L7100, UV detector L7400 and Eurosphere 100 C 18 column: 300 Â 8 mm) with 5.0 mL min À1 ow rate. Normal phase column chromatography was carried out using Merck MN Silica gel 60 M (0.04-0.063 mm) or Sephadex LH-20. TLC was carried out on precoated Silica Gel 60 F254 plates (Merck, Germany) with UV detection at 254 and 365 nm as well as following spraying with anisaldehyde reagent or with methanol-sulfuric acid (95 : 5).
Fungal material and identication
The hard coral Stylophora sp. was obtained from the Red Sea in Egypt near the coastline of Ain El-Sokhna area in November 2012. The fungal strain was isolated from the freshly crushed inner tissues of the coral following standard procedures and was identied as Gliomastix sp. according to a molecular biological protocol that was carried out through DNA amplication and sequencing of ITS region as described previously. 9, 35 The obtained data of sequencing were submitted to GenBank with the accession number KX354951. A voucher strain was deposited in the Institute of Pharmaceutical Biology and Biotechnology, Heinrich-Heine University, Düsseldorf, Germany, with the ID code ST-F3.
Cultivation, extraction and isolation
Fungal biomass fermentation was performed in Erlenmeyer asks (15 Â 1 L, each contains 100 g rice of commercially available rice and 110 mL water, which was kept overnight before being autoclaved for 20 min at a temperature of 121 C) on solid rice medium at 25 C under static conditions for 30 d.
Harvesting process started with soaking the culture of each ask in EtOAc (500 mL), in addition to cutting the culture mass into small pieces using a spatula. The asks were then kept overnight and subjected to shaking at 150 rpm for 8 h on the next day. The obtained extract was subjected to ltration, and evaporated to obtain a dark brown crude extract (6.5 g). This crude extract was partitioned between n-hexane and 90% aqueous methanol and the resulting methanolic phase was evaporated to give 4.5 g of methanolic extract, which was further chromatographed over silica gel using vacuum liquid chromatography (VLC). Gradient elution with n-hexane-EtOAc (100 : 0 to 0 : 100) and CH 2 Cl 2 -MeOH (100 : 0 to 0 : 100) was used and 500 mL eluting volume for each fraction was collected to obtain een subfractions (F1-F15).
F4 (750 mg) was subjected to a Sephadex LH-20 (100 Â 5 cm) column using MeOH as eluent to obtain six subfractions (F4-1-F4-6), of which F4-5 (80 mg) was puried using semi-preparative RP-HPLC with 60% MeOH-H 2 O as mobile phase to yield compounds 10 (42.3 mg), 11 (3.6 mg) and 12 (13.0 mg). F5 (120 mg) was further fractionated using a Sephadex LH-20 column (80 Â 4 cm) with MeOH as eluent to give ve subfractions (F5-1-F5-5). Subfraction F5-1 (34 mg) was subjected to semi-preparative RP-HPLC with 38% MeOH-H 2 O to yield 15 (14.0 mg) and 14 (3.2 mg). Subfraction F5-2 (14 mg) was puried by semi-preparative RP-HPLC using 50% MeOH-H 2 O to give 5 (1.5 mg). Subfraction F5-3 (10 mg) was separated by semipreparative RP-HPLC using 57% MeOH-H 2 O to afford 3 (0.9 mg) and 4 (2.4 mg). Subfraction F5-4 (15 mg) was puried by semi-preparative RP-HPLC with 64% MeOH-H 2 O as mobile phase to yield 1 (3.5 mg).
Following similar procedures, compound 13 (7.4 mg) was obtained from fraction F8, by column chromatography over a Sephadex LH-20 column (100 Â 5 cm) with MeOH as eluent, followed by purication using semipreparative RP-HPLC with 34% MeOH-H 2 O. F10 (235 mg) was separated into ve subfractions (F10-1-F10-5) by a Sephadex LH-20 column (80 Â 4 cm) using 100% MeOH as eluent. Subfraction F10-3 (35 mg) was then subjected to semi-preparative RP-HPLC eluted with 40% MeOH-H 2 O to yield 9 (1.8 mg) and 8 (3.0 mg) while subfraction F10-4 (13 mg) was puried by semi-preparative RP-HPLC with 50% MeOH-H 2 O to afford 2 (0.8 mg).
Compounds 7 (2.2 mg) and 6 (3.0 mg) were obtained from fraction F12 (150 mg) using a Sephadex LH-20 column (80 Â 4 cm) with MeOH for elution followed by semi-preparative HPLC separation with 35% MeOH-H 2 O as eluent.
Gliomastin A (1 
Cytotoxicity assay
The MTT method was performed to test the cytotoxicity of the compounds against the L5178Y mouse lymphoma cell line (European Collection of Authenticated Cell Cultures, Catalogue No. 87111908) as described previously. 36 Kahalalide F was used as positive control and media with 0.1% DMSO was used as negative control.
Antibacterial assay
The antibacterial assay was performed using the broth microdilution method. Following the recommendations of the Clinical and Laboratory Standards Institute (CLSI), the MIC values against S. aureus ATCC 25923, S. aureus ATCC 700699, E. faecalis ATCC 29212, E. faecalis ATCC 51299, E. faecium ATCC 35667, E. faecium ATCC 700221 and Mycobacterium tuberculosis strain H37Rv were determined.
37 Moxioxacin (for S. aureus strains), ciprooxacin (for E. faecalis and E. faecium strains) and rifampicin (for Mycobacterium tuberculosis) were used as positive controls.
Computational section
Mixed torsional/low-frequency mode conformational searches were carried out by means of the Macromodel 9.9.223 soware using the Merck Molecular Force Field (MMFF) with an implicit solvent model for CHCl 3 .
38 Geometry reoptimizations were carried out at the B3LYP/6-31G(d) level in vacuo, the B3LYP/6-31+G(d,p) level in vacuo, the B97D/TZVP 20, 21 and the CAMB3LYP/ TZVP 22,23 levels with the PCM solvent model for MeCN or MeOH. TDDFT ECD calculations and OR calculations were run with various functionals (B3LYP, BH&HLYP, CAM-B3LYP, PBE0) and the TZVP basis set as implemented in the Gaussian 09 package with the same or no solvent model as in the preceding DFT optimization step.
39 NMR calculations were performed at the mPW1PW91/6-311+G(2d,p) level.
17 ECD spectra were generated as sums of Gaussians with 3000 and 3300 cm À1 widths at halfheight (corresponding to ca. 12 and 13 nm at 200 nm), using dipole-velocity-computed rotational strength values.
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Computed ECD spectra were shied by À48 (B3LYP/TZVP for the B3LYP/6-31G(d) in vacuo conformers) for 1, +6 (PBE0/TZVP PCM/MeCN for the B97D/TZVP PCM/MeCN conformers) for 11 and À3 (B3LYP/TZVP for the B3LYP/6-31G(d) in vacuo conformers) for gliomastin E. Computed C-NMR data were corrected with I ¼ 185.4855 and S ¼ À1.0306 and H-NMR data with I ¼ 31.8996 and S ¼ À1.0734. 41, 42 Boltzmann distributions were estimated from the ZPVE-corrected B3LYP/6-31G(d) energies in the B3LYP/6-31G(d) gas-phase calculations, and from the uncorrected B3LYP/6-31+G(d,p), B97D/TZVP and CAM-B3LYP/ TZVP energies in the other cases. The MOLEKEL soware package was used for visualization of the results. 
